Similarly, the DNMT3A, TET2, PPM1D, TP53 and ASXL1 genes represent most of the CH mutation genes in MBC, NSCLC and CRPC from the American cohort.6 This evidence concerns the gene DNMT3A and non-small cell lung carcinoma.